McNally EM - Search Results

1

Targeting latent TGFβ release in muscular dystrophy.

Ceco E, Bogdanovich S, Gardner B, Miller T, DeJesus A, Earley JU, Hadhazy M, Smith LR, Barton ER, Molkentin JD, McNally EM. Ceco E, et al. Among authors: mcnally em. Sci Transl Med. 2014 Oct 22;6(259):259ra144. doi: 10.1126/scitranslmed.3010018. Sci Transl Med. 2014. PMID: 25338755 Free PMC article.

2

Caveolin-3 in muscular dystrophy.

McNally EM, de Sá Moreira E, Duggan DJ, Bönnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM. McNally EM, et al. Hum Mol Genet. 1998 May;7(5):871-7. doi: 10.1093/hmg/7.5.871. Hum Mol Genet. 1998. PMID: 9536092

3

Myoferlin, a candidate gene and potential modifier of muscular dystrophy.

Davis DB, Delmonte AJ, Ly CT, McNally EM. Davis DB, et al. Among authors: mcnally em. Hum Mol Genet. 2000 Jan 22;9(2):217-26. doi: 10.1093/hmg/9.2.217. Hum Mol Genet. 2000. PMID: 10607832

4

Sarcoglycans in muscular dystrophy.

Hack AA, Groh ME, McNally EM. Hack AA, et al. Among authors: mcnally em. Microsc Res Tech. 2000 Feb 1-15;48(3-4):167-80. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T. Microsc Res Tech. 2000. PMID: 10679964 Review.

5

Dominant negative myostatin produces hypertrophy without hyperplasia in muscle.

Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM. Zhu X, et al. Among authors: mcnally em. FEBS Lett. 2000 May 26;474(1):71-5. doi: 10.1016/s0014-5793(00)01570-2. FEBS Lett. 2000. PMID: 10828454 Free article.

6

Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. Hack AA, et al. Among authors: mcnally em. J Cell Sci. 2000 Jul;113 ( Pt 14):2535-44. doi: 10.1242/jcs.113.14.2535. J Cell Sci. 2000. PMID: 10862711

7

Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.

Zhu X, Hadhazy M, Groh ME, Wheeler MT, Wollmann R, McNally EM. Zhu X, et al. Among authors: mcnally em. J Biol Chem. 2001 Jun 15;276(24):21785-90. doi: 10.1074/jbc.M101877200. Epub 2001 Apr 3. J Biol Chem. 2001. PMID: 11287429 Free article.

8

Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.

Zhu X, Wheeler MT, Hadhazy M, Lam MY, McNally EM. Zhu X, et al. Among authors: mcnally em. FASEB J. 2002 Jul;16(9):1096-8. doi: 10.1096/fj.01-0954fje. Epub 2002 May 8. FASEB J. 2002. PMID: 12039854

9

Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy.

Wheeler MT, Zarnegar S, McNally EM. Wheeler MT, et al. Among authors: mcnally em. Hum Mol Genet. 2002 Sep 1;11(18):2147-54. doi: 10.1093/hmg/11.18.2147. Hum Mol Genet. 2002. PMID: 12189167

10

Secondary coronary artery vasospasm promotes cardiomyopathy progression.

Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM. Wheeler MT, et al. Among authors: mcnally em. Am J Pathol. 2004 Mar;164(3):1063-71. doi: 10.1016/S0002-9440(10)63193-8. Am J Pathol. 2004. PMID: 14982859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page